Sema Yarman Selected Research

Sema Yarman Research Topics

Disease

7	Prolactinoma (Prolactinomas) 02/2022 - 01/2012
7	Acromegaly 09/2020 - 10/2003
6	Neoplasms (Cancer) 06/2021 - 01/2010
4	Adenoma (Adenomas) 07/2021 - 01/2010
4	Pituitary Neoplasms (Pituitary Adenoma) 12/2018 - 01/2010
3	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2022 - 04/2015
3	Hypothyroidism 03/2018 - 12/2006
2	Hyperprolactinemia 06/2016 - 04/2015
1	Cushing Syndrome 04/2022
1	Ectopic ACTH Syndrome 04/2022
1	Pituitary ACTH Hypersecretion 04/2022
1	Thyrotoxicosis 02/2022
1	Precocious Puberty 02/2022
1	Diabetes Insipidus 07/2021
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2019
1	Polyps 09/2018
1	Growth Hormone-Secreting Pituitary Adenoma 08/2018
1	Diabetes Mellitus 05/2018
1	Insulin Resistance 05/2018
1	Glucose Metabolism Disorders 05/2018
1	Prediabetic State (Prediabetes) 05/2018
1	Hyperthyroidism 03/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Autoimmune Hypothyroidism 01/2016
1	Familial Isolated Pituitary Adenoma 07/2015
1	Combined Pituitary Hormone Deficiency 04/2015
1	Graves Disease (Basedow Disease) 06/2013
1	Thyroid Diseases (Thyroid Disease) 06/2013
1	Parkinson Disease (Parkinson's Disease) 01/2012
1	Thyroid Neoplasms (Thyroid Cancer) 07/2009
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2009
1	Agranulocytosis (Granulocytopenia) 05/2009
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Postmenopausal Osteoporosis 01/2007
1	Osteoporosis 01/2007
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2006
1	Hyponatremia 12/2006
1	Hypopituitarism (Sheehan's Syndrome) 12/2006
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 02/2004
1	Hypokalemia 01/2004
1	Adrenocortical Carcinoma 01/2004

Drug/Important Bio-Agent (IBA)

7	Dopamine Agonists (Dopamine Agonist)IBA 02/2022 - 01/2012
5	ProlactinIBA 07/2021 - 01/2012
3	Growth Hormone (Somatotropin)IBA 07/2021 - 01/2010
3	Insulin-Like Growth Factor I (IGF-1)IBA 09/2020 - 05/2018
3	Hormones (Hormone)IBA 12/2018 - 07/2015
3	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2018 - 01/2004
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2022 - 02/2004
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2019
2	aryl hydrocarbon receptor-interacting proteinIBA 12/2018 - 07/2015
1	Dehydroepiandrosterone (DHEA)IBA 04/2022
1	AntibodiesIBA 02/2022
1	Dihydroxyphenylalanine (Dopa)IBA 02/2022
1	Keratins (Keratin)IBA 01/2019
1	Insulin-Like PeptidesIBA 09/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2018
1	Anti-Mullerian HormoneIBA 01/2018
1	Thyroglobulin FDA Link 01/2016
1	AutoantibodiesIBA 01/2016
1	Iodide Peroxidase (Deiodinase)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	CytokinesIBA 06/2013
1	Interleukin-6 (Interleukin 6)IBA 06/2013
1	Interleukin-10 (Interleukin 10)IBA 06/2013
1	Pharmaceutical PreparationsIBA 01/2012
1	amsonic acid (DAS)IBA 01/2012
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2012
1	Cabergoline FDA LinkGeneric 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	IodineIBA 07/2009
1	Propylthiouracil FDA Link 05/2009
1	Diphosphonates (Bisphosphonates)IBA 01/2007
1	Clodronic Acid (Clodronate)IBA 01/2007
1	SodiumIBA 12/2006
1	DiureticsIBA 12/2006
1	GlucocorticoidsIBA 12/2006
1	HLA-B14 AntigenIBA 02/2004
1	AldosteroneIBA 01/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 10/2003

Therapy/Procedure

6	Therapeutics 06/2021 - 01/2007
1	Conservative Treatment 07/2021
1	Adrenalectomy 01/2004